Sana Biotechnology, Inc.

NASDAQ:SANA

Biotechnology

Healthcare
$1.74 +1.23%

+$0.04 today

Market cap
$521.36M
Beta
2.16
P/E (TTM)
-3.5
EPS (TTM)
-$0.87
52W Low $2.58High $6.55

Volume 4.00M

Average 3.76M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$143.83M

FY 2025 · Annual

Investing Cash Flow

-$40.24M

FY 2025 · Annual

Financing Cash Flow

$128.73M

FY 2025 · Annual

-35.6% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(355.93M)(269.48M)(283.26M)(266.76M)(244.17M)
Depreciation & Amortization11.07M15.63M24.56M17.39M12.75M
Deferred Income Tax00000
Stock-Based Compensation22.36M38.34M35.53M37.68M25.46M
Change in Working Capital9.8M7.54M18.61M(1.19M)(10.11M)
Accounts Receivables00000
Inventory00000
Accounts Payables(266K)1.06M1.03M1.38M(3.55M)
Other Working Capital10.07M6.48M17.58M(2.56M)(6.57M)
Other Non-Cash Items61.64M(82.08M)(49.03M)(10.28M)72.24M
Operating Cash Flow(251.05M)(290.05M)(253.58M)(223.15M)(143.83M)
Capital Expenditures(29.86M)(20.88M)(20.03M)(33.43M)(938K)
Acquisitions (Net)0(231.44K)(192.04K)01.43M
Purchases of Investments(491.39M)(78.69M)(157.74M)(226.06M)(87.29M)
Sales of Investments280.03M310.13M349.79M276.95M46.56M
Other Investing Activities(4.57M)231.44K192.04K17.45M0
Investing Cash Flow(245.8M)210.56M172.01M17.45M(40.24M)
Debt Repayment0007.74M(347K)
Common Stock Issued631.75M4.91M31.65M181M129.08M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities00011.01M0
Financing Cash Flow631.75M4.91M31.65M199.75M128.73M
Effect of Forex Changes00000
Net Change in Cash134.9M(74.58M)(49.92M)(5.95M)(55.33M)
Free Cash Flow(280.92M)(310.93M)(273.61M)(256.58M)(144.77M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$244.2M
+ D&A$12.8M
+ Stock-Based Comp$25.5M
+ Deferred Tax$0
- Working Capital-$10.1M
+ Other Non-Cash$72.2M
= Operating Cash Flow-$143.8M
- Capex-$938.0K
= Free Cash Flow-$144.8M

Analysis

FY2025 free cash flow is -$144.8M. FCF conversion is 59.3% of net income. Operating cash flow was -$143.8M, with capex of -$938.0K. The largest bridge item is Other Non-Cash at $72.2M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 5, 2026
SC 13G/ASC 13G/A filingNov 5, 2026
8-KCurrent reportNov 5, 2026
4Statement of changes in beneficial ownershipOct 6, 2026
8-KCurrent reportSep 8, 2026

Does SANA generate free cash flow?

Sana Biotechnology, Inc. (SANA) generated -$144.77M of free cash flow in fiscal 2025.

How much operating cash flow does SANA produce?

Operating cash flow was -$143.83M, before capital expenditures of $938,000.00.